National Bank of Canada’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.46K Sell
45
-7
-13% -$913 ﹤0.01% 2484
2025
Q4
$6.32K Sell
52
-6
-10% -$753 ﹤0.01% 2397
2025
Q3
$6.5K Sell
58
-10
-15% -$1.17K ﹤0.01% 2421
2025
Q2
$9.1K Sell
68
-17
-20% -$1.87K ﹤0.01% 2384
2025
Q1
$5.71K Buy
85
+48
+130% +$3.3K ﹤0.01% 2359
2024
Q4
$2.31K Sell
37
-375
-91% -$34.9K ﹤0.01% 2568
2024
Q3
$64.7K Buy
412
+262
+175% +$40.4K ﹤0.01% 1638
2024
Q2
$22.5K Hold
150
﹤0.01% 1930
2024
Q1
$19.5K Hold
150
﹤0.01% 2035
2023
Q4
$11.5K Hold
150
﹤0.01% 2135
2023
Q3
$7.91K Hold
150
﹤0.01% 2253
2023
Q2
$12.6K Hold
150
﹤0.01% 2120
2023
Q1
$11.4K Sell
150
-115
-43% -$7.95K ﹤0.01% 2103
2022
Q4
$16.4K Sell
265
-70
-21% -$3.72K ﹤0.01% 2057
2022
Q3
$14K Hold
335
﹤0.01% 2105
2022
Q2
$11K Hold
335
﹤0.01% 2250
2022
Q1
$9K Hold
335
﹤0.01% 2427
2021
Q4
$6K Buy
+335
New +$8.4K ﹤0.01% 2511

Other funds holding TMDX

National Bank of Canada's TMDX Position: Q1 2026 in Review

National Bank of Canada reduced its Transmedics (TMDX) stake by 13% in Q1 2026, selling an estimated $913 and leaving 45 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2484.

National Bank of Canada first reported a position in TMDX in Q4 2021 and has held it in 18 quarters since. The position peaked at $64.7K in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • National Bank of Canada held 45 shares of Transmedics worth $4.46K as of Q1 2026.
  • National Bank of Canada sold 7 Transmedics shares in Q1 2026, an estimated $913.
  • Transmedics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2484 holding.
  • National Bank of Canada first reported a position in Transmedics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Transmedics position peaked at $64.7K in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.